NCT07036185 2025-06-25A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsShanghai Bao Pharmaceuticals Co., Ltd.Phase 1 Not yet recruiting66 enrolled
NCT07030140 2025-06-22Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar CholangiocarcinomaShandong Cancer Hospital and InstitutePhase 2 Not yet recruiting38 enrolled